中微公司(688012.SH):2024年公司CCP和ICP刻蝕設備在國內主要客戶芯片生產線上市佔率持續提升
格隆匯5月9日丨中微公司(688012.SH)在互動平臺表示,公司在過去的近20年着力開發了一個完整系列的15種等離子體刻蝕設備,並積累了大量的芯片生產線量產數據和客戶驗證數據。公司的CCP電容性高能等離子體刻蝕機和ICP電感性低能等離子體刻蝕機可以覆蓋國內95%以上的刻蝕應用需求,在性能優秀、穩定性高等方面滿足了客戶先進製程中各類嚴苛要求。受益於公司完整的單臺和雙臺刻蝕設備佈局、核心技術持續突破、產品升級快速迭代、刻蝕應用覆蓋豐富等優勢,2024年公司CCP和ICP刻蝕設備在國內主要客戶芯片生產線上市佔率持續提升。公司在客戶端設備驗證、運行情況良好,具體情況請以公開披露信息爲準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.